349 related articles for article (PubMed ID: 34053456)
21. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
[TBL] [Abstract][Full Text] [Related]
22. Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells.
Kuwata H; Tomitsuka Y; Yoda E; Hara S
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35103282
[TBL] [Abstract][Full Text] [Related]
23. MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1.
Zhao G; Liang J; Zhang Y; Shan G; Bian Y; Gu J; Zhan C; Ge D
Commun Biol; 2024 Jun; 7(1):680. PubMed ID: 38831092
[TBL] [Abstract][Full Text] [Related]
24. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
25. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
[TBL] [Abstract][Full Text] [Related]
26. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
[TBL] [Abstract][Full Text] [Related]
27. Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.
Xiaofei J; Mingqing S; Miao S; Yizhen Y; Shuang Z; Qinhua X; Kai Z
Biochem Biophys Res Commun; 2021 Mar; 545():81-88. PubMed ID: 33548628
[TBL] [Abstract][Full Text] [Related]
28. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.
Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS
Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618
[TBL] [Abstract][Full Text] [Related]
29. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
Kan CF; Singh AB; Dong B; Shende VR; Liu J
Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
[TBL] [Abstract][Full Text] [Related]
30. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
[TBL] [Abstract][Full Text] [Related]
31. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
[TBL] [Abstract][Full Text] [Related]
32. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
33. ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma.
Chen P; Wang D; Xiao T; Gu W; Yang H; Yang M; Wang H
Int Immunopharmacol; 2023 Sep; 122():110629. PubMed ID: 37451020
[TBL] [Abstract][Full Text] [Related]
34. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage.
Zhou J; Tang J; Zhang C; Li G; Lin X; Liao S; Luo J; Yu G; Zheng F; Guo Z; Shao W; Hu H; Xu L; Wu S; Li H
Free Radic Biol Med; 2024 Aug; 220():271-287. PubMed ID: 38734267
[TBL] [Abstract][Full Text] [Related]
35. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
[TBL] [Abstract][Full Text] [Related]
36. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
[TBL] [Abstract][Full Text] [Related]
37. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
[TBL] [Abstract][Full Text] [Related]
38. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
Jia B; Li J; Song Y; Luo C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
[TBL] [Abstract][Full Text] [Related]
39. Identification of
Guo N
Transl Cancer Res; 2022 Aug; 11(8):2688-2699. PubMed ID: 36093519
[TBL] [Abstract][Full Text] [Related]
40. Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer.
Zhu JJ; Huang FY; Chen H; Zhang YL; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
PLoS One; 2024; 19(3):e0299571. PubMed ID: 38466744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
